Company Future Sales Volume: Harmony Biosciences Inc (HRMY)

HRMY (Harmony Biosciences) - company brandmark

The projected sales trajectory on the GURU.Markets chart reflects a trend where the indicator value stands at 1.31. Harmony Biosciences (HRMY) management ensures financial transparency and skillfully develops the asset portfolio. High business scalability is achieved through the sale of patented sleep aids with minimal costs. Optimized logistics chains and warehouse reserves completely eliminate the risk of supply disruptions.

HRMY - Harmony Corp Company Projected Revenue over the range 07/04/2022 - 11/18/2026

Summary analytical data breakdowns for Harmony Corp (HRMY)

- current price and projected stock value:
- company stock exchange capitalization indicators:
Basic company analysis:Harmony Biosciences Inc
Signature product of Harmony Pharma

This indicator determines whether a low share price masks a systemic business decline by measuring market expectations for future cash flows from product sales. By analyzing the company's projected sales figures, an investor assesses the balance between the risk of capital stagnation and growth potential, which in the case of Harmony Biosciences (HRMY) is supported by the stability of its R&D core and a focus on the commercialization of new molecules.

Competitors of Harmony Biosciences

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Projected Sales Volume BHVN|Company Future Sales Volume Amylyx Pharmaceuticals AMLX|Projected Sales Volume TRVI (Trevi Corp)|Company Future Sales Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Projected Sales Volume|CeriBell Corp (CBLL) - Company Future Sales Volume|Prothena Corp (PRTA) - Company Projected Revenue|Company Expected Sales Volume Alector Inc. (ALEC)|Company Future Sales Volume ANNX|omeros.com (OMER) - Company Future Sales|Company Projected Revenue Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Company Future Revenue|Projected Sales Volume VYGR (voyagertherapeutics.com)|Company Future Sales Neumora Therapeutics (NMRA)|SCLX - Company Projected Revenue|Company Sales Forecast Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Company Projected Revenue|CGTX - Company Future Sales|IKT (inhibikase.com) - Projected Sales Volume|cassavasciences.com (SAVA) - Company Future Sales|Company Future Sales Volume ASRT (Assertio Therapeutics)|Company Future Sales Coya Therapeutics|Vistagen - Company Future Sales Volume|ovidrx.com (OVID) - Company Expected Sales Volume|Acumen Pharmaceuticals - Projected Sales Volume|Company Expected Sales Volume cervomed.com|ATHE: Projected Sales Volume|Clene Inc - Company Future Revenue|Company Projected Revenue PepGen|JUNS (Jupiter Neurosciences Inc) - Company Projected Revenue Volume|Company Future Sales Volume RLMD (Relmada Corp)|annovisbio.com - Company Revenue Forecast|Company Projected Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Expected Revenue|KLTO - Company Projected Revenue|Company Expected Sales Volume NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Projected Revenue|Company Revenue Forecast MTVA|Company Future Sales Volume NRXS|Company Future Sales Volume Helius Medical (HSDT)|Projected Sales Volume PASG|Neuphoria Therapeutics - Company Revenue Forecast|Company Projected Revenue Minerva Neurosciences, Inc. NERV|Projected Sales Volume Athira Pharma ATHA|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics